This trial is no longer available!
Search for a recruiting clinical trial for your condition
Your journey
1What's a trial
4Get in touch
More info
You can access this
clinical trial
if you have
Duchenne Muscular Dystrophy
and you are
between 5 and 80
years old
The phase for this study is not defined.
Show me locations

The purpose

This is a phase IIIb, multi-centre, open-label extension study in male subjects with DMD who previously have been treated with drisapersen, aiming at assessing the safety and efficacy of drisapersen.

Provided treatments

  • Drug: Drisapersen

Locations near you

Unfortunately, there are no recruiting locations near you. Please check the list with all locations below.
Tris trial is registered with FDA with number: NCT02636686. The sponsor of the trial is BioMarin Pharmaceutical and it is looking for 0 volunteers for the current phase.
Official trial title:
An Open-label Extension Study of the Long-term Safety, Tolerability and Efficacy of Drisapersen in Subjects With Duchenne Muscular Dystrophy.